Lantz Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$230K Buy
+341
New +$203K 0.04% 245
2026
Q1
– Sell
-375
Closed -$217K – 254
2025
Q4
$217K Buy
+375
New +$212K 0.05% 238
2025
Q2
– Sell
-597
Closed -$297K – 241
2025
Q1
$297K Buy
597
+4
+0.7% +$2.17K 0.08% 177
2024
Q4
$308K Buy
593
+3
+0.5% +$1.65K 0.08% 176
2024
Q3
$365K Buy
590
+28
+5% +$16.6K 0.1% 163
2024
Q2
$311K Sell
562
-9
-2% -$5.16K 0.1% 166
2024
Q1
$332K Buy
571
+87
+18% +$48.8K 0.11% 152
2023
Q4
$257K Buy
484
+73
+18% +$35.3K 0.09% 174
2023
Q3
$208K Buy
411
+8
+2% +$4.26K 0.08% 173
2023
Q2
$210K Buy
403
+2
+0.5% +$1.08K 0.08% 180
2023
Q1
$231K Hold
401
– – 0.1% 169
2022
Q4
$221K Buy
+401
New +$212K 0.1% 165

Other funds holding TMO

Lantz Financial's TMO Position: Q3 2026 in Review

Lantz Financial opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 341 shares worth $230K. The stake represents 0.04% of the portfolio and ranks #245 among its holdings. This is a return to the name: Lantz Financial previously reported a position in TMO as recently as Q4 2025.

Lantz Financial first reported a position in TMO in Q4 2022 and has held it in 12 quarters since. The position peaked at $365K in Q3 2024. 2,797 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Lantz Financial held 341 shares of Thermo Fisher Scientific worth $230K as of Q3 2026.
  • Thermo Fisher Scientific was a new Lantz Financial position in Q3 2026.
  • Thermo Fisher Scientific made up 0.04% of Lantz Financial's portfolio in Q3 2026, its #245 holding.
  • Lantz Financial first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 12 quarters since.
  • Lantz Financial's Thermo Fisher Scientific position peaked at $365K in Q3 2024.
  • 2,797 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Lantz Financial's 13F filing for Q3 2026, filed 15 Oct 2026.